Capital World Investors Biomarin Pharmaceutical Inc Transaction History

Capital World Investors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $238 - $372	-3 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $178 Million - $241 Million	-2,493,175 Reduced 100.0%	3 $0
Q4 2019 Feb 18, 2020	BUY	$64.27 - $86.37 $89,463 - $120,227	1,392 Added 0.06%	2,493,178 $211 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $4.43 Million - $5.59 Million	65,704 Added 2.71%	2,491,786 $168 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $70.1 Million - $81.9 Million	872,055 Added 56.12%	2,426,082 $208 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $28.3 Million - $33.1 Million	336,000 Added 27.59%	1,554,027 $138 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $99.7 Million - $132 Million	-1,243,814 Reduced 50.52%	1,218,027 $104 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $59.1 Million - $66.5 Million	628,738 Added 34.3%	2,461,841 $239 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $12 Million - $15.7 Million	158,184 Added 9.44%	1,833,103 $173 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $17.1 Million - $20.4 Million	220,309 Added 15.15%	1,674,919 $136 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $18.4 Million - $21.6 Million	227,456 Added 18.54%	1,454,610 $130 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $98.9 Million - $117 Million	1,227,154	1,227,154 $114 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.